NO20043723L - Farmasoytisk doseringform for avgivese gjennom slimhinner - Google Patents

Farmasoytisk doseringform for avgivese gjennom slimhinner

Info

Publication number
NO20043723L
NO20043723L NO20043723A NO20043723A NO20043723L NO 20043723 L NO20043723 L NO 20043723L NO 20043723 A NO20043723 A NO 20043723A NO 20043723 A NO20043723 A NO 20043723A NO 20043723 L NO20043723 L NO 20043723L
Authority
NO
Norway
Prior art keywords
delivery
mucosa
dosage form
pharmaceutical dosage
tablet
Prior art date
Application number
NO20043723A
Other languages
English (en)
Norwegian (no)
Inventor
Alice C Martino
Steven A Pierman
Robert M Noack
Nancy Britten
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of NO20043723L publication Critical patent/NO20043723L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20043723A 2002-02-07 2004-09-06 Farmasoytisk doseringform for avgivese gjennom slimhinner NO20043723L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35570302P 2002-02-07 2002-02-07
PCT/US2003/003836 WO2003066029A2 (en) 2002-02-07 2003-02-06 Pharmaceutical dosage form for mucosal delivery

Publications (1)

Publication Number Publication Date
NO20043723L true NO20043723L (no) 2004-09-06

Family

ID=27734551

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043723A NO20043723L (no) 2002-02-07 2004-09-06 Farmasoytisk doseringform for avgivese gjennom slimhinner

Country Status (21)

Country Link
US (1) US20030235617A1 (de)
EP (1) EP1471890B1 (de)
JP (1) JP2005519924A (de)
KR (1) KR100666520B1 (de)
CN (1) CN100346832C (de)
AT (1) ATE340565T1 (de)
AU (1) AU2003215110B2 (de)
BR (1) BR0307473A (de)
CA (1) CA2474190A1 (de)
CO (1) CO5611096A2 (de)
DE (1) DE60308647T2 (de)
DK (1) DK1471890T3 (de)
ES (1) ES2271542T3 (de)
MX (1) MXPA04007728A (de)
NO (1) NO20043723L (de)
NZ (1) NZ534340A (de)
PL (1) PL372290A1 (de)
PT (1) PT1471890E (de)
RU (1) RU2285520C2 (de)
WO (1) WO2003066029A2 (de)
ZA (1) ZA200405614B (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
BRPI0302736B8 (pt) * 2003-06-02 2021-05-25 Ems S/A composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
SE0401031D0 (sv) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
JP5004236B2 (ja) * 2005-02-09 2012-08-22 キッセイ薬品工業株式会社 口腔内崩壊錠
US8744546B2 (en) 2005-05-05 2014-06-03 Dexcom, Inc. Cellulosic-based resistance domain for an analyte sensor
CN106727271B (zh) * 2006-01-06 2020-02-14 阿塞尔Rx制药有限公司 小体积口腔经粘膜剂型
US20100179215A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US20090042972A1 (en) * 2006-05-19 2009-02-12 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20110318412A1 (en) * 2006-05-19 2011-12-29 Somaxon Pharmaceuticals, Inc. Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
US20080058408A1 (en) * 2006-05-19 2008-03-06 Rogowski Roberta L Low-dose doxepin for treatment of sleep disorders in elderly patients
US20100227916A1 (en) * 2006-05-19 2010-09-09 Somaxon Pharmaceuticals, Inc N-desmethyl-doxepin and methods of using the same to treat sleep disorders
WO2007142810A2 (en) * 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20090042971A1 (en) * 2006-05-19 2009-02-12 Somaxon Pharmaceuticals, Inc. Method of using low-dose doxepin for the improvement of sleep
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
KR101140110B1 (ko) * 2006-07-07 2012-06-04 테바 파마슈티컬 인더스트리즈 리미티드 타달라필 및 하나 이상의 담체를 포함하는 고체 조성물
WO2008011150A1 (en) 2006-07-20 2008-01-24 Somaxon Pharmaceuticals, Inc. Methods of improving the pharmacokinetics of doxepin
US20080182890A1 (en) * 2006-10-04 2008-07-31 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
WO2008052139A2 (en) 2006-10-25 2008-05-02 Somaxon Pharmaceuticals, Inc. Ultra low dose doxepin and methods of using the same to treat sleep disorders
WO2008070795A2 (en) * 2006-12-06 2008-06-12 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
US20090074862A1 (en) 2007-04-13 2009-03-19 Luigi Schioppi Low-dose doxepin formulations and methods of making and using the same
JP2010525082A (ja) * 2007-04-25 2010-07-22 テバ ファーマシューティカル インダストリーズ リミティド 固体投与形
DE102007028869A1 (de) * 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
CN102395270B (zh) * 2008-07-07 2014-11-12 法斯根公司 化合物、含有其的药物组合物、其使用方法及其制备方法
CN101757623B (zh) * 2008-10-09 2013-12-04 北京德众万全药物技术开发有限公司 一种5-ht受体激动剂固体药物组合物
TWI455733B (zh) 2009-03-30 2014-10-11 Toray Industries 口腔內崩壞性被覆錠劑
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
EA015250B9 (ru) * 2010-11-19 2013-10-30 Тева Фармасьютикал Индастриз, Лтд. Таблетка силденафила, обеспечивающая модифицированную фармакокинетику, и способ ее изготовления
US20120195954A1 (en) * 2011-02-02 2012-08-02 Roxiticus Health Products, Llc Method of Reducing Appetite
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
BR112014026439B1 (pt) * 2012-04-27 2022-05-31 Merck Patent Gmbh Formulação farmacêutica sob a forma de um comprimido revestido, e seu processo de preparação
ES2880399T3 (es) * 2012-07-27 2021-11-24 Neurodyn Life Sciences Inc Biodisponibilidad cerebral mejorada de galantamina mediante formulaciones seleccionadas y administración transmucosa de profármacos lipofílicos
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015122477A1 (ja) 2014-02-12 2015-08-20 沢井製薬株式会社 フィルムコーティングされた口腔内崩壊錠
US9561233B2 (en) 2014-03-13 2017-02-07 Demerx, Inc. Use of ibogaine for the treatment of pain
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US9592239B2 (en) 2014-09-12 2017-03-14 Demerx, Inc. Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake
CA2964628A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
JP6529822B2 (ja) * 2015-05-22 2019-06-12 東和薬品株式会社 トリプタン系化合物を含有する口腔内崩壊錠
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
RU2649834C1 (ru) * 2016-07-06 2018-04-04 Фармалидер С.А. Фармацевтическая композиция силденафила цитрата в форме суспензии для перорального применения
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
EP3807260B1 (de) 2018-06-15 2024-09-18 R. J. Reynolds Tobacco Company Reinigung von nikotin
WO2020180608A1 (en) * 2019-03-01 2020-09-10 Insignis Therapeutics, Inc. Dipivefrin orally disintegrating tablet formulations
AU2020258086A1 (en) 2019-04-17 2021-11-11 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
CN111499545B (zh) * 2020-04-27 2022-05-03 武汉英纳氏药业有限公司 一种对氨基取代苯酚类化合物的制备方法
EP4221693A1 (de) 2020-09-29 2023-08-09 Millicent Pharma Limited Im mund dispergierbare formulierungen
CN116457021A (zh) 2020-11-25 2023-07-18 英特维特国际股份有限公司 通过氟尼辛的颊部施用治疗疼痛的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181966A1 (de) * 1984-11-13 1986-05-28 Gist-Brocades N.V. Pressdragierte dispergierbare Tabletten
US5273975A (en) * 1989-06-09 1993-12-28 The Upjohn Company Heterocyclic amines having central nervous system activity
AU680345B2 (en) * 1994-01-27 1997-07-24 Board Of Regents Of The University Of Oklahoma, The Rapidly dissolving oral dosage form
US6121276A (en) * 1994-04-22 2000-09-19 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
DE10199068I2 (de) * 1994-04-22 2004-05-06 Pentech Pharmaceuticals Inc Sublinguale Dosierungsformen enthaltend apomorphinzur Verwendung bei der Behandlung von erektiler D ysfunktion.
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5888534A (en) * 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
GB9616672D0 (en) * 1996-08-08 1996-09-25 Scherer Ltd R P Pharmaceutical compositions
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
WO1999022769A1 (en) * 1997-10-31 1999-05-14 Monsanto Company Gellan gum tablet coating
MXPA00012199A (es) * 1998-06-10 2003-07-14 Monsanto Plc Composicion de goma de gelano modificada, proceso para la preparacion de la misma y uso de esta.
WO2000007584A2 (en) * 1998-08-04 2000-02-17 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
US5994363A (en) * 1998-08-24 1999-11-30 Pentech Pharmaceuticals, Inc. Amelioration of apomorphine adverse effects
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
TWI256309B (en) * 1999-10-13 2006-06-11 Akzo Nobel Nv New formulation of mirtazapine
KR100661684B1 (ko) * 2002-02-07 2006-12-26 파마시아 코포레이션 약학적 정제

Also Published As

Publication number Publication date
CN1627938A (zh) 2005-06-15
PL372290A1 (en) 2005-07-11
RU2004124057A (ru) 2005-04-20
EP1471890B1 (de) 2006-09-27
DE60308647T2 (de) 2007-08-09
PT1471890E (pt) 2007-01-31
ATE340565T1 (de) 2006-10-15
AU2003215110B2 (en) 2007-11-29
KR100666520B1 (ko) 2007-01-11
MXPA04007728A (es) 2004-11-10
ES2271542T3 (es) 2007-04-16
KR20040083503A (ko) 2004-10-02
BR0307473A (pt) 2004-11-09
CO5611096A2 (es) 2006-02-28
WO2003066029A3 (en) 2003-10-16
JP2005519924A (ja) 2005-07-07
CA2474190A1 (en) 2003-08-14
CN100346832C (zh) 2007-11-07
US20030235617A1 (en) 2003-12-25
EP1471890A2 (de) 2004-11-03
ZA200405614B (en) 2005-06-27
RU2285520C2 (ru) 2006-10-20
WO2003066029A2 (en) 2003-08-14
DK1471890T3 (da) 2007-01-08
DE60308647D1 (de) 2006-11-09
NZ534340A (en) 2006-04-28
AU2003215110A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
NO20043723L (no) Farmasoytisk doseringform for avgivese gjennom slimhinner
DK1419765T3 (da) Fremgangsmåde til fremstilling af analgetiske tabletter omfattende et brusende reaktant-par til administration over mundslimhinden
MXPA02004235A (es) Dosificacion de farmacos a traves de la mucosa oral usando una solucion solida.
EP2444072A3 (de) Nichtmukoadhäsive Filmdosierungsformen
ATE346591T1 (de) Pharmazeutische tablette
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
WO2003047519A3 (en) 'compressed annular tablet with molded triturate tablet for oral and intraoral'
NO20071505L (no) Fremgangsmate for sammensetting av legemiddelavgivelsesanordninger.
AR060931A1 (es) Producto farmaceutico recubierto para la administracion intraoral de nicotina y su uso y elaboracion
IL196425A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
NO20071795L (no) Octenidin-inneholdende tabletter anvendt mot betennelsessykdommer i munn og svelg
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
CY1112964T1 (el) Κιτ για φαρμακευτικη χρηση
ATE292453T1 (de) Antivirale arznei
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
JP2005525329A5 (de)
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
RU2004129284A (ru) Амброксол для лечения болей в полости рта и глотки
DE602005008128D1 (de) Cytisinehaltiges Arzneimittel
Bhoi et al. An Innovative approach for Oral Drug Delivery System
GB0224492D0 (en) Pharmaceutical compositions of rapid drug delivery system to carry active ingredients for fast dissolving tablets by mouth administration
MY145885A (en) Controlled release formulations for oral administration

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application